Jeffrey W. Organ

MicroTransponder, Inc. develops wireless neurostimulation system for the treatment of chronic pain and other neurological indications. It is a medical device company spun out from the University of Texas at Dallas. The firm has an team of neuroengineers collaborating with academics to develop wireless solutions to treat neurological diseases. The company was founded by Lawrence James Cauller, Thomas James Curnes II and William Michael Rosellini in June 2009 and is headquartered in Austin, TX.

OrthoAccel Technologies, Inc. develops, manufactures and markets orthodontic devices. The firm engages in the development, manufacture and marketing of products to enhance dental care and orthodontic treatment. It develops and sells AcceleDent, a FDA-cleared clinical approach to safely accelerate orthodontic tooth movement by applying gentle micropulses, SoftPulse Technology, as a complement to existing orthodontic treatment. The company was founded by Mark Kwatia, Kirk A. Purcell, Lawrence W. Swol, Colin I. James and Anna Lisa Somera in 2007 and is headquartered in Bellaire, TX.

GEN3 Partners, Inc. provides world-class product, process and packaging innovation services. It is a technical innovation solutions provider that focuses on product, process, and packaging innovation for many of the largest and most respected industrial, consumer goods, and medical device companies in the world. The firm specializes in technical innovation consulting, training, product portfolio diagnosis, benchmarking, roadmap development and IP strategy. The company was founded by Michael Treacy, Simon S. Litvin and James K. Sims in 1999 and is headquartered in Boston, MA.

37celsius Capital Partners LLC (37celsius Capital Partners) is a private equity firm founded in 2016 by Alexander Kempe. The firm is headquartered in Milwaukee, Wisconsin.